ATE302025T1 - Vorrichtungen zur behandlung und diagnose des restless leg syndroms - Google Patents
Vorrichtungen zur behandlung und diagnose des restless leg syndromsInfo
- Publication number
- ATE302025T1 ATE302025T1 AT99957453T AT99957453T ATE302025T1 AT E302025 T1 ATE302025 T1 AT E302025T1 AT 99957453 T AT99957453 T AT 99957453T AT 99957453 T AT99957453 T AT 99957453T AT E302025 T1 ATE302025 T1 AT E302025T1
- Authority
- AT
- Austria
- Prior art keywords
- cei
- sleep
- agonist
- diagnosis
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Advance Control (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9803760A SE9803760D0 (sv) | 1998-11-04 | 1998-11-04 | Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel |
PCT/SE1999/001979 WO2000025821A1 (en) | 1998-11-04 | 1999-11-03 | Method of treating and diagnosing restless legs syndrome and corresponding means |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE302025T1 true ATE302025T1 (de) | 2005-09-15 |
Family
ID=20413169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99957453T ATE302025T1 (de) | 1998-11-04 | 1999-11-03 | Vorrichtungen zur behandlung und diagnose des restless leg syndroms |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1154795B1 (de) |
AT (1) | ATE302025T1 (de) |
DE (1) | DE69926804T2 (de) |
DK (1) | DK1154795T3 (de) |
ES (1) | ES2251242T3 (de) |
SE (1) | SE9803760D0 (de) |
WO (1) | WO2000025821A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2314893C (en) | 1997-12-22 | 2005-09-13 | Euro-Celtique, S.A. | Opioid agonist/antagonist combinations |
US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
DE19938823A1 (de) * | 1999-08-19 | 2001-02-22 | Boehringer Ingelheim Pharma | Medikamentöse Behandlung des Restless Leg Syndroms |
PT1380306E (pt) | 2001-03-30 | 2009-05-25 | Toray Industries | Medicamentos para psiconeurose |
DE60238756D1 (de) | 2001-05-11 | 2011-02-10 | Endo Pharmaceuticals Inc | Opioid enthaltende arzneiform gegen missbrauch |
EP1492506B2 (de) | 2002-04-05 | 2016-06-29 | Euro-Celtique S.A. | Matrix für die modifizierte freigabe von aktiven substanzen |
US6960571B2 (en) * | 2003-03-14 | 2005-11-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
US7297691B2 (en) * | 2003-08-13 | 2007-11-20 | Janssen Pharmaceutica N.V. | Treatment of sleep disorders with cholinesterase inhibitors |
CN1898201A (zh) | 2003-10-21 | 2007-01-17 | 森蒂有限公司 | 可抑制胆碱酯酶和释放药理学活性试剂的氨基甲酸酯 |
DK1742624T3 (da) * | 2004-02-18 | 2010-03-08 | Sepracor Inc | Dopamin-agonist-kombinationsterapi med sedativer til forbedring af søvnkvalitet |
EP1604667A1 (de) * | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioide zur Behandlung des Restless Leg Syndroms |
EP1702558A1 (de) | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Verfahren und Vorrichtung zur Darmtätigkeitserfassung |
EP1891946A1 (de) * | 2006-08-14 | 2008-02-27 | Santhera Pharmaceuticals (Schweiz) AG | Transmukosale Verabreichung von 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinon |
JP2010518010A (ja) | 2007-02-02 | 2010-05-27 | コルシド・ファーマシューティカルズ・インコーポレイテッド | コリンエステラーゼを阻害する化合物 |
US20090048229A1 (en) * | 2007-07-18 | 2009-02-19 | Rupniak Nadia M J | Methods for promoting wakefulness |
MX347106B (es) | 2009-03-10 | 2017-04-12 | Euro-Celtique S A * | Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona. |
EP2251010A1 (de) | 2009-05-08 | 2010-11-17 | Sygnis Bioscience GmbH & Co. KG | Verwendungen von Thiabendazol und Derivaten davon zur Behandlung neurologischer Leiden |
WO2011101866A2 (en) | 2010-02-17 | 2011-08-25 | Sun Pharma Advanced Research Company Ltd., | A method of treating a disease condition susceptible to baclofen therapy |
CA2918004C (en) | 2013-07-23 | 2018-11-20 | Euro-Celtique S.A. | A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPO274596A0 (en) * | 1996-10-04 | 1996-10-31 | Armstrong, Stuart Maxwell | Method for the treatment of neurological or neuropsychiatric disorders |
DE19701619B4 (de) * | 1997-01-17 | 2007-10-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Pramipexol zur Behandlung des restless legs syndroms |
-
1998
- 1998-11-04 SE SE9803760A patent/SE9803760D0/xx unknown
-
1999
- 1999-11-03 EP EP99957453A patent/EP1154795B1/de not_active Expired - Lifetime
- 1999-11-03 DK DK99957453T patent/DK1154795T3/da active
- 1999-11-03 AT AT99957453T patent/ATE302025T1/de not_active IP Right Cessation
- 1999-11-03 DE DE69926804T patent/DE69926804T2/de not_active Expired - Fee Related
- 1999-11-03 ES ES99957453T patent/ES2251242T3/es not_active Expired - Lifetime
- 1999-11-03 WO PCT/SE1999/001979 patent/WO2000025821A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE69926804T2 (de) | 2006-06-22 |
ES2251242T3 (es) | 2006-04-16 |
DE69926804D1 (de) | 2005-09-22 |
SE9803760D0 (sv) | 1998-11-04 |
EP1154795B1 (de) | 2005-08-17 |
EP1154795A1 (de) | 2001-11-21 |
DK1154795T3 (da) | 2006-01-02 |
WO2000025821A1 (en) | 2000-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE302025T1 (de) | Vorrichtungen zur behandlung und diagnose des restless leg syndroms | |
DK0668863T3 (da) | Quinuclidinderivat som substans P-antagonist | |
BR0108977A (pt) | Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina | |
DE60101201D1 (de) | Verwendung von nikotinergen acetylcholinrezeptor-agonisten zur herstellung eines medikaments zur behandlung von keratoconjuctivitis sicca | |
DE69400799D1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
PT1326613E (pt) | Utilizacao de derivados de imidazo[1,2-a]piridin-,imidazo[1,2-a]pirimidin- e imidazo[1,2-a]pirazin-3-il-amina substituidos para a fabricacao de medicamentos para inibicao de nos | |
CY1107452T1 (el) | Διαδερμικη μορφη χορηγησης για τη θεραπεια του συνδρομου ανησυχων ποδιων | |
DE60042215D1 (de) | Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit | |
DE60316779D1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
BR0111980A (pt) | Amina substituìda, composto protegido, métodos para tratar um paciente que tenha ou para prevenir que um paciente contraia uma doença ou condição, para inibir a atividade da beta-secretase, para inibir a clivagem da proteìna precursora de amilóide (app), para inibir a produção do peptìdeo beta amilóide (a beta) em uma célula, para inibir a produção de placa beta0amilóide em um animal, e para tratar ou prevenir uma doença compreendendo depósitos de beta-amilóide no cérebro, composição método para produzir um complexo de beta-secretase, conjunto, e, uso de amina substituìda | |
ES2166111T3 (es) | Uso de tiagabina para el tratamiento de trastornos del sueño. | |
BR0211119A (pt) | Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto | |
HUP0202570A1 (hu) | Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk | |
ATE359068T1 (de) | Methode zur behandlung der symptome hormoneller veränderungen, einschliesslich hitzewallungen | |
SE0002754D0 (sv) | New pharmaceutical combination formulation and method of treatment with the combination | |
DE602005024571D1 (de) | Opioide zur behandlung von ruhelosigkeit in den unteren gliedmassen | |
ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
HUP0401501A2 (hu) | Érrendszeri gyulladás kezelése vagy megelőzése szterin-felszívódást gátló anyagokat tartalmazó gyógyszerkészítmények alkalmazásával | |
UA35567C2 (uk) | Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату | |
ATE469907T1 (de) | Triptolid-analoga zur behandlung von autoimmunkranheiten und entzündungen | |
DE69726143D1 (de) | Verwendung von pharmazeutische Zusammensetzungen enthaltend Thymol und/oder Carvacrol in der Behandlung von Histomoniasis | |
SE0004101D0 (sv) | New use | |
DE69822810D1 (de) | Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x | |
HUP0001913A2 (hu) | Pramipexole alkalmazása állandóan mozgó láb szindróma kezelésére szolgáló gyógyszerkészítmények előállítására | |
BR9502072A (pt) | Composto metodo para o tratamento de uma condiçao médica e composiçao farmaceutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEIH | Change in the person of patent owner | ||
UEP | Publication of translation of european patent specification |
Ref document number: 1154795 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |